<i>In vivo</i> administration of gut bacterial consortia replicates urolithin metabotypes A and B in a non-urolithin-producing rat model
Carlos E. Iglesias‐Aguirre, Antonio González‐Sarrías, Adrián Cortés‐Martín, María Romo‐Vaquero, Leire Osuna‐Galisteo, J. M. Castro Cerón, Juan Carlos Espı́n, María V. Selma
Abstract
genera in faecal samples. These results suggest that the bacterial consortia are safe and could be potential probiotics for human trials, which is especially relevant for UM-0 individuals, who cannot produce bioactive Uros.
Topics & Concepts
In vivoChemistryPharmacologyBiologyBiotechnologyPomegranate: compositions and health benefitsSesame and Sesamin ResearchCynara cardunculus studies